Target intelligence / Profile preview

Ribosomal protein L7 pseudogene 32 (RPL7P32)

Target
RPL7P32
Molecular classification
Other (Pseudogene)
01

Overview

Ribosomal protein L7 pseudogene 32 (RPL7P32) is a processed pseudogene in the human genome, closely related to the functional ribosomal protein L7 (RPL7) gene. Pseudogenes like RPL7P32 are genomic DNA sequences similar to functional genes but generally lack protein-coding potential due to mutations or truncations and are typically not transcribed into functional proteins[2][7][10][11]. RPL7P32 was cataloged in gene databases because it shares sequence similarity with RPL7, a component of the large (60S) ribosomal subunit, but does not encode a functional protein[2][10][11]. Pseudogenes, including RPL7P32, are generally not considered therapeutic targets such as receptors, enzymes, or transporters because they do not produce functional proteins and typically lack biological activity. While emerging research has shown that some pseudogenes have regulatory roles at the RNA level in certain contexts, no evidence exists for RPL7P32 having any drug interactions, biomarker relevance, or direct disease association[2][7][10][11]. Its primary scientific importance lies in genome annotation and evolutionary studies rather than molecular targeting.

Other names
RPL7PRPL7_15_834WUGSC:H_RG054D04.1

Beyond the preview

Go deeper on Ribosomal protein L7 pseudogene 32 (RPL7P32).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L7 pseudogene 32 (RPL7P32).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call